PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BBIO vs. ^GSPC
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Correlation

The correlation between BBIO and ^GSPC is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

BBIO vs. ^GSPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BridgeBio Pharma, Inc. (BBIO) and S&P 500 (^GSPC). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%JulyAugustSeptemberOctoberNovemberDecember
22.04%
10.43%
BBIO
^GSPC

Key characteristics

Sharpe Ratio

BBIO:

-0.55

^GSPC:

2.16

Sortino Ratio

BBIO:

-0.54

^GSPC:

2.87

Omega Ratio

BBIO:

0.94

^GSPC:

1.40

Calmar Ratio

BBIO:

-0.44

^GSPC:

3.19

Martin Ratio

BBIO:

-0.84

^GSPC:

13.87

Ulcer Index

BBIO:

36.41%

^GSPC:

1.95%

Daily Std Dev

BBIO:

55.59%

^GSPC:

12.54%

Max Drawdown

BBIO:

-92.80%

^GSPC:

-56.78%

Current Drawdown

BBIO:

-60.57%

^GSPC:

-0.82%

Returns By Period

In the year-to-date period, BBIO achieves a -29.33% return, which is significantly lower than ^GSPC's 26.63% return.


BBIO

YTD

-29.33%

1M

21.82%

6M

22.03%

1Y

-30.52%

5Y*

-7.90%

10Y*

N/A

^GSPC

YTD

26.63%

1M

1.18%

6M

10.44%

1Y

27.03%

5Y*

13.30%

10Y*

11.23%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BBIO vs. ^GSPC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BridgeBio Pharma, Inc. (BBIO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BBIO, currently valued at -0.55, compared to the broader market-4.00-2.000.002.00-0.552.16
The chart of Sortino ratio for BBIO, currently valued at -0.54, compared to the broader market-4.00-2.000.002.004.00-0.542.87
The chart of Omega ratio for BBIO, currently valued at 0.94, compared to the broader market0.501.001.502.000.941.40
The chart of Calmar ratio for BBIO, currently valued at -0.44, compared to the broader market0.002.004.006.00-0.443.19
The chart of Martin ratio for BBIO, currently valued at -0.84, compared to the broader market0.0010.0020.00-0.8413.87
BBIO
^GSPC

The current BBIO Sharpe Ratio is -0.55, which is lower than the ^GSPC Sharpe Ratio of 2.16. The chart below compares the historical Sharpe Ratios of BBIO and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.55
2.16
BBIO
^GSPC

Drawdowns

BBIO vs. ^GSPC - Drawdown Comparison

The maximum BBIO drawdown since its inception was -92.80%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for BBIO and ^GSPC. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-60.57%
-0.82%
BBIO
^GSPC

Volatility

BBIO vs. ^GSPC - Volatility Comparison

BridgeBio Pharma, Inc. (BBIO) has a higher volatility of 20.69% compared to S&P 500 (^GSPC) at 3.96%. This indicates that BBIO's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
20.69%
3.96%
BBIO
^GSPC
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab